Real-world comparative effectiveness of neoadjuvant chemoimmunotherapy versus chemotherapy for locally advanced esophageal squamous cell carcinoma: a retrospective cohort study
Neoadjuvant chemoimmunotherapy (NCIT) has shown higher pathologic response rates than neoadjuvant chemotherapy (NCT) in patients with locally advanced esophageal squamous cell carcinoma (LA-ESCC). Recent studies have reported comparative survival outcomes, but evidence from extended follow-up remains limited....